Oryan A, Hassanajili S, Sahvieh S
Department of Pathobiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Department of Chemical Engineering, School of Chemical and Petroleum Engineering, Shiraz University, Shiraz, Iran.
Iran J Vet Res. 2023;24(2):122-125. doi: 10.22099/IJVR.2023.43807.6421.
Abstract.
One of the most common concerns in the regeneration of massive bone defects necessitating surgery and bone grafts is the application of tissue engineering using drug delivery. Zoledronate is a well-known effective drug for the healing bone fractures in osteoporotic patients.
An attempt was made to design a more efficient bone scaffold with polycaprolactone, polylactic acid, and hydroxyapatite.
The scaffold was fabricated by freeze-drying and indirect 3D printing approaches. X-ray diffraction, Fourier transform infrared spectroscopy, rheometry, scanning electron microscopy, and neutral red tests were performed to characterize the scaffold. qRT-PCR was also done to define the osteoinductivity and angiogenic induction capacity of this scaffold. Forty rats were selected and randomly divided into four groups: the control group, which received no treatment, the autograft group, scaffold group, and Zol-loaded scaffold group (n=10 in each group). The injured area was studied by radiology, biomechanical analysis, histopathology, histomorphometry, immunohistochemistry, and CT scan analyses.
The qRT-PCR results demonstrated significantly higher expression levels of , , and markers in the scaffold group when compared to the control group (P<0.05). Histopathologically, the newly formed bone tissue was significantly detected in the Zol-loaded scaffold and autograft groups in comparison with the non-treated group (P<0.001). The immunohistochemistry (OC marker), biomechanical, and histomorphometric results indicated a significant improvement in the regeneration of the injured area in the groups treated with autologous bone and Zol-loaded scaffold compared to the non-treated group (P<0.05). The Zol-loaded scaffold accelerated bone regeneration, and led to enhanced structural performance and functional ability of the injured radial bone in rats.
摘要。
在需要手术和骨移植的大块骨缺损再生中,最常见的问题之一是利用药物递送的组织工程应用。唑来膦酸盐是治疗骨质疏松症患者骨折的一种知名有效药物。
尝试用聚己内酯、聚乳酸和羟基磷灰石设计一种更高效的骨支架。
通过冷冻干燥和间接3D打印方法制备支架。进行X射线衍射、傅里叶变换红外光谱、流变学、扫描电子显微镜和中性红试验以表征支架。还进行了qRT-PCR以确定该支架的骨诱导性和血管生成诱导能力。选择40只大鼠并随机分为四组:对照组,不接受任何治疗;自体移植组、支架组和载唑来膦酸盐支架组(每组n = 10)。通过放射学、生物力学分析、组织病理学、组织形态计量学、免疫组织化学和CT扫描分析研究损伤区域。
与对照组相比,qRT-PCR结果显示支架组中 、 和 标志物的表达水平显著更高(P < 0.05)。组织病理学上,与未治疗组相比,在载唑来膦酸盐支架组和自体移植组中明显检测到新形成的骨组织(P < 0.001)。免疫组织化学(OC标志物)、生物力学和组织形态计量学结果表明,与未治疗组相比,自体骨和载唑来膦酸盐支架治疗组损伤区域的再生有显著改善(P < 0.05)。载唑来膦酸盐支架加速了骨再生,并提高了大鼠损伤桡骨的结构性能和功能能力。